Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Clinical trial NCT06361316 · RECRUITING
Trial details
- NCT number
- NCT06361316
- Sponsor
- Kuirong Jiang
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-08
- Primary completion
- 2025-03-25
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.